TrialBeacon
OTHERClinicalTrials.govClinical trialNot applicableNot yet recruiting

Dyadic Physical Activity Intervention for Children Undergoing Cancer Treatment

Open the official recordBack

Official record

Identifier
NCT07737418
Recruiting locations
Locations are not included in the offline baseline for this record. Open the official record to see the current site list.
Interventions studied
Dyadic Physical Activity InterventionIndividual InterventionPsychological Support
Lead sponsor
The Hong Kong Polytechnic University
Target enrolment
198 participants
Study type
INTERVENTIONAL
Phase
Not applicable
Status
Not yet recruiting
First posted
Jul 30, 2026
Last updated on the registry
Jul 31, 2026
Age
9 Years – 18 Years
Sex
ALL
Study contact
The official record lists a study contact. Contact details are published there and are intentionally not copied to this page.
Eligibility criteria

Reproduced verbatim from the official record. Eligibility is decided by the study team, never by this page.

Inclusion Criteria:

* Children aged 9-18 years old
* Diagnosed with leukaemia
* Currently undergoing maintenance therapy
* Have a parent willing to participate in the study
* Both the child and participating parent speak Cantonese and read Chinese

Exclusion Criteria:

* Children under palliative care with evidence of cancer recurrence or second malignancies
* Children with medical contraindications for PA, such as thrombosis, as documented by physicians
* Children or parents with physical impairment or cognitive and learning problems (identified from medical records)
* Participants in the team's other interventional studies
Indexed under
Leukemia

This site does not provide medical advice

TrialBeacon only aggregates links to publicly available official information. It does not recommend, rank or evaluate any treatment, trial or medicine, and nothing here implies suitability for any individual. Please discuss anything you find with your treating doctor, and always rely on the original official page — records change over time. Full disclaimer.